SCOPUS 정보 검색 플랫폼

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 4, 2013, Pages 743-744

Re: Is viscoelastic evidence of hyperfibrinolysis the ideal indicator for tranexamic acid administration in trauma?

(5) Napolitano, Lena M a Cohen, Mitchell J b Cotton, Bryan A c Schreiber, Martin A d Moore, Ernest E e

a UNIVERSITY OF MICHIGAN (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c UNIVERSITY OF TEXAS MEDICAL SCHOOL (United States)

d OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

e DENVER HEALTH MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL PROTOCOL; FIBRINOLYSIS; FISHERMAN; HUMAN; HYPERFIBRINOLYSIS; INJURY; LETTER; MORTALITY; PLASMA TRANSFUSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE TRANSFUSION; VISCOELASTICITY;

ANTIFIBRINOLYTIC AGENTS; HUMANS; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84885349956 PISSN: 21630755 EISSN: 21630763 Source Type: Journal
DOI: 10.1097/01.ta.0000436141.01515.9a Document Type: Letter

Times cited : (2)

References (5)

1
- 84880409778
- Diagnosis of hyperfibrinolysis in trauma requires further validation
- Ramos CR, Moore EE, Manco-Johnson ML, Silliman CC, Chapman MC, Banerjee A. Diagnosis of hyperfibrinolysis in trauma requires further validation. J Thromb Haemost. 2013; 11:1435-1437.
- (2013) J Thromb Haemost. , vol.11 , pp. 1435-1437
- Ramos, C.R.¹ Moore, E.E.² Manco-Johnson, M.L.³ Silliman, C.C.⁴ Chapman, M.C.⁵ Banerjee, A.⁶

2
- 84864633119
- Hyperfibrinolysis on admission is an uncommon but highly lethal event associated with shock and pre-hospital fluid administration
- Cotton BA, Harvin JA, Kostousouv V, Minei KM,Radwan ZA, Schöchl H,Wade CE,Holcomb JB, Matijevic N. Hyperfibrinolysis on admission is an uncommon but highly lethal event associated with shock and pre-hospital fluid administration. J Trauma Acute Care Surg. 2012; 73(2):365-370.
- (2012) J Trauma Acute Care Surg. , vol.73 , Issue.2 , pp. 365-370
- Cotton, B.A.¹ Harvin, J.A.² Kostousouv, V.³ Minei, K.M.⁴ Radwan, Z.A.⁵ Schöchl, H.⁶ Wade, C.E.⁷ Holcomb, J.B.⁸ Matijevic, N.⁹

3
- 84885358498
- Fibrinolysis above 3% is the critical value for initiation of antifibrinolytic therapy in trauma
- in press
- ChapmanMP, Moore EE, GhasabyanA,Harr JN, Chin TL,Ramos CR, Stringham JR, Silliman CC, Banerjee A. Fibrinolysis above 3% is the critical value for initiation of antifibrinolytic therapy in trauma. J Trauma Acute Care Surg. [in press].
- J Trauma Acute Care Surg
- Chapman, M.P.¹ Moore, E.E.² Ghasabyan, A.³ Harr, J.N.⁴ Chin, T.L.⁵ Ramos, C.R.⁶ Stringham, J.R.⁷ Silliman, C.C.⁸ Banerjee, A.⁹

4
- 84874254007
- The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks
- PROMMTT Study Group
- Holcomb JB, del Junco DJ, Fox EE,Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, et al.; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127-136.
- (2013) JAMA Surg. , vol.148 , Issue.2 , pp. 127-136
- Holcomb, J.B.¹ Del Junco, D.J.² Fox, E.E.³ Wade, C.E.⁴ Cohen, M.J.⁵ Schreiber, M.A.⁶ Alarcon, L.H.⁷ Bai, Y.⁸ Brasel, K.J.⁹ Bulger, E.M.¹⁰

5
- 84857508828
- Avoidable mortality from giving tranexamic acid to bleeding trauma patients: An estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
- Ker K, Kiriya J, Perel P, Edwards P, Shakur H, Roberts I. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med. 2012;12:3.
- (2012) BMC Emerg Med. , vol.12 , pp. 3
- Ker, K.¹ Kiriya, J.² Perel, P.³ Edwards, P.⁴ Shakur, H.⁵ Roberts, I.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.